Sign In
Buy VNDA
$5.10
-0.0800 (-1.54%)
At Close: Jul 31, 2026
Shareholder Alert: Robbins LLP Announces that Vanda Pharmaceuticals Inc. (VNDA) Class Action Survives Motion to Dismiss
01:52pm, Thursday, 11'th Mar 2021
SAN DIEGO & WASHINGTON--(BUSINESS WIRE)---- $VNDA #ClassAction--Shareholder rights law firm Robbins LLP announces that Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) may face damages caused by a pending se
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2020 Results - Earnings Call Transcript
09:11pm, Wednesday, 10'th Feb 2021
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2020 Results - Earnings Call Transcript
Here's Why Vanda Pharmaceuticals Jumped Higher Today
03:02pm, Wednesday, 02'nd Dec 2020
The biotech's sleep drug Hetlioz gained an expanded approval.
Vanda Investors Can Sleep Easy With This FDA Approval
09:11am, Wednesday, 02'nd Dec 2020
News of an update from the U.S. Food and Drug Administration (FDA) pushed Vanda Pharmaceuticals Inc.
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
06:22pm, Tuesday, 01'st Dec 2020
WASHINGTON, Dec. 1, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q3 2020 Results - Earnings Call Transcript
09:43pm, Wednesday, 28'th Oct 2020
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q3 2020 Results - Earnings Call Transcript
5 Ben Graham Lost Formula Stocks With High Financial Strength
04:26pm, Wednesday, 28'th Oct 2020
As markets continue sliding on economic recovery slowdown fears, five Ben Graham Lost Formula stocks with high financial strength are Sabine Royalty Trust (NYSE:SBR), XBiotech Inc. (NASDAQ:XBIT), Cata
